Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
March 29 Product: Gileads Vemlidy Indication: Chronic hepatitis B in pediatric patients Gilead has scored a label extension for its antiviral Vemlidy, which is now available for pediatric patients ages six and older with chronic hepatitis B virus (HBV) with compensated liver disease who weigh at least 25 kg
None of the 38 verified that buyers were actual researchers
These datasets require validation because pathway enrichment does not establish functional biological outcomes
Without adequate protein, even a perfectly calculated calorie target will not prevent muscle loss
No head-to-head trial exists: Every number below comes from two separate Phase 2 programs, so the comparison is directional only
US$ 24.26
US$ 28.98
US$ 29.51
US$ 20.01
US$ 29.42
US$ 22.61
US$ 29.45
US$ 26.74
